CD4<sup>+</sup> and CD8a<sup>+</sup> PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer modelsLotte K. Kristensen, Andreas Kjær|Theranostics|2019Cited by 105
Abstract 570: Preclinical insights into 161Tb-trastuzumab and immune checkpoint combination therapy for cancer in a HER2-expressing murine cancer modelSigrid Cold, Lotte K. Kristensen, Pragalath Sadasivam et al.|Cancer Research|2025Cited by 0
In Vivo Studies of [ <sup>161</sup> Tb]Tb-Trastuzumab Radiopharmaceutical Therapy in Human Epidermal Growth Factor Receptor 2–Expressing Breast Tumors Show High Tumor Uptake and Tumor Growth SuppressionSigrid Cold, Lotte K. Kristensen, Jesper Fonslet et al.|Journal of Nuclear Medicine|2026Cited by 0